- Home
- SYRE vs BALY Comparison
SYRE vs BALY Comparison
Compare SYRE & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- BALY
- Stock Information
- Founded
- SYRE 2013
- BALY 2004
- Country
- SYRE United States
- BALY United States
- Employees
- SYRE N/A
- BALY 10000
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- BALY Hotels/Resorts
- Sector
- SYRE Health Care
- BALY Consumer Discretionary
- Exchange
- SYRE Nasdaq
- BALY Nasdaq
- Market Cap
- SYRE 897.9M
- BALY 737.4M
- IPO Year
- SYRE 2016
- BALY N/A
- Fundamental
- Price
- SYRE $12.67
- BALY $18.04
- Analyst Decision
- SYRE Buy
- BALY Hold
- Analyst Count
- SYRE 8
- BALY 7
- Target Price
- SYRE $50.00
- BALY $18.00
- AVG Volume (30 Days)
- SYRE 899.5K
- BALY 363.4K
- Earning Date
- SYRE 05-08-2025
- BALY 02-19-2025
- Dividend Yield
- SYRE N/A
- BALY N/A
- EPS Growth
- SYRE N/A
- BALY N/A
- EPS
- SYRE N/A
- BALY N/A
- Revenue
- SYRE N/A
- BALY $2,481,783,000.00
- Revenue This Year
- SYRE N/A
- BALY $3.06
- Revenue Next Year
- SYRE N/A
- BALY N/A
- P/E Ratio
- SYRE N/A
- BALY N/A
- Revenue Growth
- SYRE N/A
- BALY 2.80
- 52 Week Low
- SYRE $10.91
- BALY $9.74
- 52 Week High
- SYRE $40.49
- BALY $18.38
- Technical
- Relative Strength Index (RSI)
- SYRE 36.18
- BALY 60.77
- Support Level
- SYRE $12.04
- BALY $14.67
- Resistance Level
- SYRE $13.29
- BALY $15.79
- Average True Range (ATR)
- SYRE 1.27
- BALY 2.04
- MACD
- SYRE 0.01
- BALY 0.58
- Stochastic Oscillator
- SYRE 26.02
- BALY 97.51
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.